Catalogo dei prodotti della ricerca

MAROCCO, RAFFAELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.598
EU - Europa 858
AS - Asia 389
SA - Sud America 19
AF - Africa 12
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.879
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.547
IT - Italia 418
IN - India 167
SE - Svezia 146
SG - Singapore 114
CN - Cina 89
UA - Ucraina 61
FI - Finlandia 55
DE - Germania 42
CA - Canada 41
IE - Irlanda 30
BG - Bulgaria 24
GB - Regno Unito 16
AR - Argentina 15
RO - Romania 14
AT - Austria 10
FR - Francia 9
MY - Malesia 9
CZ - Repubblica Ceca 8
MX - Messico 6
BE - Belgio 5
EG - Egitto 5
NL - Olanda 5
BR - Brasile 4
BZ - Belize 4
MK - Macedonia 4
PH - Filippine 3
RU - Federazione Russa 3
TG - Togo 3
AU - Australia 2
CH - Svizzera 2
HK - Hong Kong 2
JP - Giappone 2
NG - Nigeria 2
PL - Polonia 2
AL - Albania 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
KR - Corea 1
LV - Lettonia 1
SC - Seychelles 1
TR - Turchia 1
TZ - Tanzania 1
VN - Vietnam 1
Totale 3.879
Salva come PNG Salva come JPEG
Città #
Fairfield 407
Chandler 203
Ashburn 196
Woodbridge 186
Dearborn 184
Rome 159
Seattle 140
Houston 134
Cambridge 129
Wilmington 124
Ann Arbor 81
Princeton 76
Plano 56
Milan 54
Singapore 48
San Paolo di Civitate 47
Fremont 45
Beijing 40
Lawrence 37
Boston 30
Dublin 30
New York 30
Ottawa 29
San Diego 28
Millbury 26
Sofia 24
Jacksonville 18
Andover 17
Norwalk 17
Federal 15
San Mateo 14
Helsinki 11
San Jose 11
Solbiate Olona 10
Brno 8
Pune 8
Toronto 8
Vienna 8
Artena 7
Bühl 7
Phoenix 7
Kunming 6
Prato 6
Boardman 5
Brussels 5
Hefei 5
Mexico City 5
Sabaudia 5
Belize City 4
Bremen 4
Des Moines 4
Falls Church 4
Genoa 4
Grafing 4
Induno Olona 4
Nanchang 4
Nanjing 4
Naples 4
Barrie 3
Buffalo 3
Dallas 3
Dasmariñas 3
Guangzhou 3
Lomé 3
London 3
Mannheim 3
Munich 3
Providence 3
Shenyang 3
Simi Valley 3
Abuja 2
Baotou 2
Bern 2
Chengdu 2
Chicago 2
Chiyoda-ku 2
Columbus 2
Corsalone 2
Fuzhou 2
Hangzhou 2
Hong Kong 2
Jinan 2
Laurel 2
Lingolsheim 2
Negrar 2
Osimo 2
Rho 2
Ribera 2
San Michele al Tagliamento 2
Shanghai 2
Southend 2
Stockholm 2
Tappahannock 2
Warsaw 2
Americana 1
Amsterdam 1
Anandanagar 1
Auburn Hills 1
Bangalore 1
Budapest 1
Totale 2.876
Salva come PNG Salva come JPEG
Nome #
Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents 131
Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection 110
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) 100
Legionella pneumophila pneumonia during telaprevir-based triple therapy for HCV chronic hepatitis 99
Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon 98
Multifunctional analysis of CD4+T-cell response as immune-based model for tuberculosis detection 96
Herpes virus reactivation after initiation of interferon-free antiviral agents in HIV-HCV-coinfected subjects: a new immune restoration disease? 92
Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: a multicentre case series 92
Blood myeloid dendritic cells and slandc in antiretroviral therapy-suppressed hiv-infected patients 91
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters 85
Hepatitis B reactivation despite entecavir prophylaxis in a patient with chronic lymphocytic leukaemia receiving bendamustine 85
Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV 84
Glucose Plasma Levels and Pregnancy Outcomes in Women with HIV 82
Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV reactivation following a rituximab-based regimen 81
Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy 80
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors 79
Diagnostic and therapeutic approach in a rare case of primary bilateral adrenal tuberculosis 78
Postpartum fever in the presence of a fibroid: Sphingomonas paucimobilis sepsis associated with pyomyoma 74
Bartonella henselae infection presenting with ocular and hepatosplenic manifestations in an immunocompetent child 73
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection 69
Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment 68
Severe and Persistent Depletion of Circulating Plasmacytoid Dendritic Cells in Patients with 2009 Pandemic H1N1 Infection 68
Use of Specific Antiretroviral Regimens Among HIV-Infected Women in Italy at Time of Conception: 2001–2011 68
Quantitative ultrasound (QUS) in HIV-infected patients: a reliable and low-cost technique for bone health assessment 66
Increased sCD163 and sCD14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID-19 pneumonia 66
Good prenatal detection rate of major birth defects in HIV-infected pregnant women in Italy 65
Downregulation of Leukocyte Migration After Treatment With CCR5 Antagonist Maraviroc 65
Late onset invasive pneumococcal disease in a liver transplanted patient: beyond the Austrian syndrome 64
Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia. A retrospective cohort study 62
Role of interferon-gamma release assays (IGRAs) for the screening of latent tuberculosis infection in patients candidates for TNF-α antagonist 62
null 61
Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme. Convergent or divergent action? 61
Comparative evaluation of subtyping tools for surveillance of newly emerging HIV-1 strains 61
Rate, correlates and outcomes of repeat pregnancy in HIV-infected women 60
Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis. 59
Pregnancy outcomes in HIV-infected women of advanced maternal age 56
Deficit severo e persistente delle cellule dendritiche plasmocitoidi nei pazienti con influenza 2009 H1N1 53
Atazanavir and darunavir in pregnant women with HIV: Evaluation of laboratory and clinical outcomes from an observational national study 53
ROLE OF INTERFERON-Gamma RELEASE ASSAYS (IGRAS) IN HIV-SSOCIATED TUBERCULOSIS: IN VITRO AND IN VIVO EFFECT OF ANTITUBERCULOUS DRUGS 50
null 49
HIV-ASSOCIATED PML:AN IMMUNE-MEDIATED DEREGULATION DISEASE? 47
In vivo and in vitro effects of antituberculosis treatment on mycobacterial Interferon-gamma T cell response. 46
Use of remdesivir in patients with SARS-CoV-2 Pneumonia in a real-life setting during the second and third COVID-19 epidemic waves 45
Molecular identification of new cases of human Dirofilariosis (Dirofilaria repens) in Italy 43
Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients 43
Blood glucose and epicardial adipose tissue at the hospital admission as possible predictors for COVID-19 severity 42
Successful treatment of Stenotrophomonas maltophilia soft tissue infection with tigecycline: a case report 40
PORPHYRIA CUTANEA TARDA IN TWO ARV-SUPPRESSED PATIENTS WITH HIV/HCV COINFECTION 40
Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment. 39
Severe and Persistent Impairment of Innate Immune Response in Patients with H1N1-Related Pneumonia 37
USEFULNESS OF QUANTITATIVE ULTRASONOGRAPHY (QUS) FOR BONE HEALTH ASSESSMENT IN HIV-INFECTED PATIENTS 35
null 35
HORMONAL STATUS AND NATURAL IMMUNITY IN HIV INFECTED PATIENTS 34
Hiv Tropism and Use of Maraviroc In Clinical Practice 33
Quantitative ultrasound in HIV-infected patients as a surrogate marker of early bone damage 29
A case of primary central nervous system lymphoma in advanced naive {HIV}-infected patient. The role of antiviral agents 27
Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use 27
null 27
Longitudinal virological and immunological profile in a case of human monkeypox infection 27
Immunity and hormonal status in HIV-infected women: study of dendritic cells, CCR5 expression, IFN-alpha response and immune activation markers 25
Immunogenicity and efficacy of vaccination in people living with human immunodeficiency virus 24
null 24
Systemic, mucosal immune activation and psycho-sexual health in art-suppressed women living with HIV. Evaluating biomarkers and environmental stimuli 23
SEVERE OSTEOPOROSIS IN A YOUNG HIV-INFECTED MAN TREATED WITH TERIPATIDE 23
“IGRAs assay for the screening of latent TB infection in patients candidate for TNF-α antagonist” 23
Abstracts of ICI 2016 International Congress of Immunology, 21-26 August 2016, Melbourne, Australia 23
Impatto della terapia antitubercolare sul rilascio di interferon-GAMMA al test QUANTIFERON-TB GOLD”. 19
HIV Associated PML: an immune-mediated deregulationa disease? 19
Evaluation of blood plasmacytoid dendritic cells and inflammatory monocytes during firstwave HCV protease inhibitor therapy 18
“Interferon-g release assay (IGRA) nello screening della tubercolosi latente nei pazienti candidati al trattamento con antagonisti del TNFα” 18
“Usefulness of interferon-gamma release assays for latent tuberculosis screening in patients candidate for TNF-g therapy” 18
HCV-related diabetes: Still looking for a definition 15
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection 15
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection. Prospective cohort study 14
Baseline myeloid and lymphoid activation markers can predict time to viral load reduction under 50 copies/mL and CD4 recovery, respectively, after highly active antiretroviral therapy initiation 14
“Role of Interferon-γ Release Assays (IGRAs) in HIV-Associated Tuberculosis: in Vitro and in Vivo Effect of Antituberculous Drugs” 13
Longitudinal assessment of multiple immunological and inflammatory parameters during successful DAA therapy in HCV monoinfected and HIV/HCV coinfected subjects 11
null 9
Peripheral Blood Inflammatory Monocytes are Increased in Hcv Infected Subjects in Comparison with Art Treated Hcv/hiv Coinfected with Similar Fibrosis Stage 7
Effectiveness, tolerability and prescribing choice of antiviral molecules molnupiravir, remdesivir and nirmatrelvir/r. A real-world comparison in the first ten months of use 5
null 3
null 3
Totale 4.058
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.549
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020928 0 24 5 76 142 180 167 103 94 78 23 36
2020/2021345 49 39 8 13 10 40 3 26 61 47 24 25
2021/2022681 9 41 76 32 94 11 26 77 50 47 90 128
2022/2023789 144 142 44 76 81 90 11 60 86 4 32 19
2023/2024507 24 50 15 34 49 86 19 23 4 95 46 62
2024/202539 39 0 0 0 0 0 0 0 0 0 0 0
Totale 4.058